检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:罗信[1] 彭霞[1] 陈广成[1] 侯婧瑛[2] 吴淑云 王凌云[1]
机构地区:[1]中山大学孙逸仙纪念医院消化内科,广东广州510120 [2]中山大学孙逸仙纪念医院急诊科,广东广州510120 [3]中山大学肿瘤防治中心胸外科,广东广州510060
出 处:《中国病理生理杂志》2017年第12期2179-2187,共9页Chinese Journal of Pathophysiology
基 金:广州市科技计划项目(No.201704020121)
摘 要:目的:构建高效的siRNA纳米载体靶向SGC-7901胃癌细胞,并下调胃癌表达的程序性死亡配体1(PD-L1)。方法:检测叶酸(FA)-PEG-SS-PEI-SPION纳米载体与siRNA复合后的粒径、电位等表征;体外实验检验siRNA的结合能力、复合物细胞毒性、细胞摄入能力及转染效率;磁共振(MR)成像检测示踪能力;检验胃癌细胞PD-L1下调效应及共培养T细胞的细胞因子水平。结果:N/P比值为10时,FA-PEG-SS-PEI-SPION完全复合siRNA,形成电位为(9.14±0.80)m V、粒径为(116.7±2.5)nm的多聚复合物。靶向组的转染率为(95.06±0.44)%,与非靶向组的(93.87±1.05)%相当;平均荧光强度为1 892.67±81.51,高于非靶向组的1 324.33±186.58(P<0.05)。普鲁士蓝染色和激光共聚焦显微镜成像证实了复合物的细胞摄入。体外MR成像验证了聚合物的MR造影成像能力。靶向组PD-L1的mRNA最低相对表达量为9.07%±0.79%,Western blot显示PD-L1的表达显著降低。共培养实验显示IFN-γ和TNF-α的分泌水平增加,IL-10的分泌水平降低(P<0.05)。结论:本研究构建了FA-PEG-SS-PEI-SPION纳米载体,并证明了其体外靶向细胞及载siRNA下调PD-L1表达的能力和MR示踪的能力,是一种高效和安全的靶向治疗纳米载体。AIM: To synthesis and characterize a multi-functional siRNA delivery agent with effective thera-peutic effects and MR-tracing ability for programmed death ligand-1 ( PD-L1) positive gastric cancer SGC-7901 cell line. METHODS: The characterization, binding ability, cytotoxicity, transfection efficiency and cellular internalization of the polyplex were determined. The PD-L1 knockdown effect was analyzed, and cytokines secreted by cocultured T cells were measured. RESULTS : We developed folic acid ( FA) -PEG-SS-PEI-SPION as siRNA delivery agent for PD-L1 knockdown. At W//3 ratio of 10,the FA-PEG-SS-PEI-SPION bound PD-L1 siRNA to form polyplex in a diameter of (116. 7 ±2. 5) nm with zeta potential of (9. 14 ±0. 80) mV. Transfection efficiency of the targeted polyplex was ( 95. 06 ± 0. 44) % ,com- pared with (93. 87 ±1.05)% of the untargeted polyplex. Mean fluorescence intensity of the targeted polyplex was 1 892. 67 ±81. 51,significantly higher than 1 324. 33 ± 186. 58 of the untargeted. The cellular magnetic resonance (MR) imaging showed the polyplex also acted as T2 weighted contrast agent for cancer MR imaging. The relative mRNA level of PD-L1 in polymer/siRNA-2 treatment group was (9. 07 ± 0. 79) % . Decreased protein expression of PD-L1 was showed by Western blot. The secretion levels of IFN-7 and TNF-a in cocultured T cells increased, while that of IL-10 decreased. CONCLUSION : Our findings highlighted the potential of the multifunctional theranostic nanoparticles for effective targe-ting PD-LI knockdown therapy and MR imaging diagnosis in gastric cancers.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.188.184.3